Medivive partners with leaders in drug development, clinical education, and pharmaceutical quality to bring the best NAD+ product to US physicians and their patients.
SpectrumX is the UK-based development partner behind the Medivive NAD+ pen. SpectrumX invested in a full drug development program to formulate a high-integrity NAD+ solution and deliver it in a prefilled subcutaneous injector pen.
SpectrumX holds a Medical Specials license in the UK. Medivive is SpectrumX's exclusive partner for US commercialization. Through technology transfer led by Medivive, the formulation is manufactured at VeV Scientific in San Diego to the same standard as the original UK program.
Medivive is a Trusted Partner of the SSRP Institute, a leading clinical education organization for cellular medicine and peptide therapeutics founded by Dr. William Seeds, MD.
The SSRP Trusted Partner program is invitation-only and compensation-free. Partners are nominated by SSRP Fellows and reviewed internally. The Institute promotes brands that its faculty trusts and uses in clinical protocols.
Medivive's inclusion reflects confidence in the quality and clinical value of the prefilled NAD+ injector pen.
Dr. William Seeds is the Founder and Academic Chairman of the SSRP Institute and Founder and Medical Director of the Redox Medical Group in Beverly Hills. He is a board-certified surgeon and sports medicine specialist with over 40 years of clinical experience.
Dr. Seeds is the best-selling author of Peptide Protocols, Volume 1 and has trained thousands of clinicians through SSRP in cellular medicine and peptide therapeutics.
In a recent Redox Revolution episode, Dr. Seeds discusses the clinical rationale for subcutaneous NAD+ delivery and the Medivive prefilled injector pen.
FDA-registered cGMP 503B outsourcing facility in San Diego. Manufactures the Medivive NAD+ pen via formal technology transfer from SpectrumX.
Licensed 503A dispensing pharmacy with PCAB accreditation and LegitScript certification. Ships cold-chain to patients in 41 states.
Medivive works with physician networks, clinical educators, and healthcare organizations advancing access to high-quality compounded therapeutics.